Company intelligence
Roche Diagnostics UK & Ireland
Doing now what patients need next
About Roche Diagnostics UK & Ireland
At Roche Diagnostics we put patients at the heart of everything we do. We work with healthcare systems to develop and integrate diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. We offer the industry’s most comprehensive in vitro diagnostics solutions, covering molecular diagnostics, clinical chemistry and immunoassays, tissue diagnostics, point of care testing, patient self-testing, next-generation sequencing, and laboratory automation and IT, and decision support solutions. We see social media as an opportunity to share what is important to us, and also to stay close to our community and hear your voices. You can interact with us via @mentions, comments or direct messages. We do our best to stay connected with you and reply to queries as quickly as we can. However, as much as we would love to stay in touch, we operate in a highly regulated industry and some conversations we cannot allow on our channels. Read our community guidelines here: https://diagnostics.roche.com/us/en/about-us/social-media-community-guidelines.html
Verified activity
Signals from Roche Diagnostics UK & Ireland
4 published signals
Research & Knowledge
Roche Diagnostics UK & Ireland supported the Surrey and Borders Partnership NHS Foundation Trust trial NCT07717411 testing a new Alzheimer's drug on people without symptoms.
Reported by Roche Diagnostics UK & Ireland
Research & Knowledge
Roche Diagnostics UK & Ireland published new research from the Alzheimer's Society showing that nearly half of surveyed individuals waited more than six months for an accurate dementia diagnosis after visiting their GP.
Reported by Roche Diagnostics UK & Ireland
Presence & Recognition
Roche Diagnostics UK & Ireland announced a virtual event featuring Spanish and international key opinion leaders (KOLs) deep-dive into cutting-edge clinical, diagnostic, and biomarker updates in angiogenic factors in placental insufficiency on 23 October 2026.
Reported by Julia Eades
Presence & Recognition
Roche Diagnostics UK & Ireland employee Richard Knox will be doing the same as your team, my day role as a Roche employee and training when I can.
Reported by Richard Knox